First Citizens BancShares Inc (Delaware)
NASDAQ:FCNCA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
First Citizens BancShares Inc (Delaware)
NASDAQ:FCNCA
|
US |
|
A
|
AstraZeneca PLC
STO:AZN
|
UK |
|
Cardiff Oncology Inc
NASDAQ:CRDF
|
US |
|
Eaton Corporation PLC
NYSE:ETN
|
IE |
|
N
|
New Residential Investment Corp
LSE:0K76
|
US |
|
W
|
Wolters Kluwer NV
XHAM:WOSB
|
NL |
|
Investis Holding SA
SIX:IREN
|
CH |
|
A
|
Adecco Group AG
F:ADI1
|
CH |
|
HSBC Holdings PLC
LSE:HSBA
|
UK |
Wall St Price Targets
FCNCA Price Targets Summary
First Citizens BancShares Inc (Delaware)
According to Wall Street analysts, the average 1-year price target for FCNCA is 2 262.55 USD with a low forecast of 2 070.5 USD and a high forecast of 2 598.75 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FCNCA's stock price target?
Price Target
2 262.55
USD
According to Wall Street analysts, the average 1-year price target for FCNCA is 2 262.55 USD with a low forecast of 2 070.5 USD and a high forecast of 2 598.75 USD.
What is the Revenue forecast for First Citizens BancShares Inc (Delaware)?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 3 years is 3%.
What is the Net Income forecast for First Citizens BancShares Inc (Delaware)?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Net Income has been 24%. The projected CAGR for the next 8 years is 9%.
